Limbal Stem Cell Deficiency

Synonyms

LSCD,

Overview

Limbal stem cell deficiency (LSCD) is a condition where damage to the stem cells at the edge of the cornea (limbus) causes failure to repair the corneal surface. This leads to conjunctival tissue growing over the cornea (conjunctivalization), resulting in chronic pain, vision loss, inflammation, and potential blindness. 

Symptoms

Limbal stem cell deficiency (LSCD) causes chronic eye pain, blurred vision, severe light sensitivity, and intense redness due to the loss of corneal surface stability. Symptoms, often misdiagnosed as severe dry eye, include foreign body sensation, constant tearing, and contact lens intolerance, frequently leading to poor wound healing and potentially blinding corneal scarring

Causes

Limbal Stem Cell Deficiency (LSCD) is caused by damage to the stem cells located at the limbus (the edge of the cornea), resulting from acquired, congenital, or idiopathic factors. Key causes include chemical/thermal burns, chronic inflammation (e.g., Stevens-Johnson Syndrome), contact lens misuse, and iatrogenic damage from surgeries or medication. 

Prevention

Preventing limbal stem cell deficiency (LSCD) focuses on avoiding damage to the eye’s surface, primarily through protective eyewear against injuries and managing chronic inflammation. Key measures include preventing chemical/thermal burns, avoiding contact lens over-wear, controlling autoimmune disorders, and managing surface infections. 

Diagnosis

Limbal Stem Cell Deficiency (LSCD) is diagnosed through a combination of clinical history, slit-lamp examination (often using fluorescein), and specialized tests, primarily impression cytology. Key indicators include conjunctivalization of the cornea (conjunctival cells growing onto the cornea), persistent epithelial defects, neovascularization, and persistent eye pain/irritation.

Prognosis

Limbal stem cell deficiency (LSCD) prognosis varies from good to poor, depending on severity and the success of surgical intervention. Early-stage cases may stabilize with treatment, while late-stage cases require stem cell transplantation to prevent permanent vision loss from corneal scarring. Successful procedures, such as Simple Limbal Epithelial Transplantation (SLET), can lead to significant visual improvement, with successful outcomes often lasting for years. 

Treatment

Limbal stem cell deficiency (LSCD) treatment aims to restore the ocular surface, reduce inflammation, and improve vision, primarily through stem cell transplantation. Key methods include Simple Limbal Epithelial Transplantation (SLET) and Conjunctival Limbal Autograft (CLAU) for unilateral cases, and allogenic transplants (CLAL/KLAL) for bilateral cases. Cultivated Limbal Epithelial Transplantation (CLET) and emerging technologies like CALEC offer advanced options.